Kymera Therapeutics (KYMR) Market Capitalization (2020 - 2026)
Kymera Therapeutics' Market Capitalization came in at $9.49 billion for Q2 2026, up 208.3% from $3.08 billion a year earlier and up 38.7% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Market Capitalization was $6.33 billion, up 142.4% from FY2024.
- Market Capitalization has increased in each of the last three years, with a five-year compound annual growth rate of 42.5% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $2.61 billion in FY2024 (+84.5%), $1.42 billion in FY2023 (+3.0%), $1.37 billion in FY2022 (-58.0%) and $3.27 billion in FY2021 (+204.2%).
- The Q2 2026 figure represents the highest quarterly Market Capitalization in data going back to Q3 2020.
- Year-over-year, Market Capitalization has increased for five consecutive quarters, with growth averaging 136.1% over the last eight quarters.
- The fastest year-over-year change in Market Capitalization over five years came in Q3 2021 (growth of 350.7%), and the weakest in Q3 2022 (a decline of 60.4%).
- Business Quant data shows KYMR's Market Capitalization at $6.84 billion (Q1 2026), $6.33 billion (Q4 2025) and $4.06 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn |
| 10 | Kymera Therapeutics | 11.30 Bn | 8.60 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.49 Bn |
| Mar 31, 2026 | 6.84 Bn |
| Dec 31, 2025 | 6.33 Bn |
| Sep 30, 2025 | 4.06 Bn |
| Jun 30, 2025 | 3.08 Bn |
| Mar 31, 2025 | 1.78 Bn |
| Dec 31, 2024 | 2.61 Bn |
| Sep 30, 2024 | 3.06 Bn |
| Jun 30, 2024 | 1.84 Bn |
| Mar 31, 2024 | 2.47 Bn |
| Dec 31, 2023 | 1.42 Bn |
| Sep 30, 2023 | 770.76 Mn |
| Jun 30, 2023 | 1.27 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 2.19 Bn |
| Dec 31, 2021 | 3.27 Bn |
| Sep 30, 2021 | 3.01 Bn |
API Access
Kymera Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();